Merck discontinues development of 2 cancer drugs after trial failures

(Reuters) – Merck said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials.

(Reporting by Leroy Leo in Bengaluru; Editing by Alan Barona)